Aprea Therapeutics (APRE) Cash from Financing Activities (2018 - 2026)
Aprea Therapeutics (APRE) reported Cash from Financing Activities of -$1.94 million for Q2 2026, compared with $384,879 a year earlier.
Powered by 
Analysis
Aprea Therapeutics (APRE) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aprea Therapeutics' Cash from Financing Activities came in at $36.89 million; for FY2025, it came in at $4.64 million, down 68.7% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of 98.4% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $14.82 million in FY2024 (+188.4%), $5.14 million in FY2023 (+652.6%), $682,973 in FY2022 (-60.9%) and $1.75 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities since Q3 2019.
- Per Business Quant data, the three quarters before Q2 2026 came in at $34.62 million (Q1 2026), $3.84 million (Q4 2025) and $357,940 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Aprea Therapeutics | 40.11 Mn | 40.11 Mn | - | -1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.94 Mn |
| Mar 31, 2026 | 34.62 Mn |
| Dec 31, 2025 | 3.84 Mn |
| Sep 30, 2025 | 357,940.00 |
| Jun 30, 2025 | 384,879.00 |
| Mar 31, 2025 | 55,849.00 |
| Dec 31, 2024 | 134,405.00 |
| Sep 30, 2024 | -1,155.00 |
| Jun 30, 2024 | -21,060.00 |
| Mar 31, 2024 | 14.71 Mn |
| Mar 31, 2023 | 5.14 Mn |
| Dec 31, 2022 | 98,526.00 |
| Dec 31, 2021 | 1.66 Mn |
| Jun 30, 2020 | 121,426.00 |
| Mar 31, 2020 | 29,523.00 |
| Dec 31, 2019 | 91.20 Mn |
| Sep 30, 2019 | -3.62 Mn |
| Jun 30, 2019 | -435,798.00 |
| Mar 31, 2019 | 5.43 Mn |
| Dec 31, 2018 | 56.37 Mn |
API Access
Aprea Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();